A/Prof. Hongqiang Qiu (Fuzhou, China)
A/Prof. Hongqiang Qiu obtained a PhD in pharmacology and holds positions as Chief Pharmacist, Associate Professor, and Master’s Supervisor at Fujian Medical University Union Hospital. He is recognized as a High-Level Talent in Fujian Province and a key researcher at the National Drug clinical Trial Registration Institution. A/Prof. Qiu serves as the Deputy Director of the Committee on Pharmaceutical Genetics and Pharmacogenomics of the Fujian Pharmaceutical Association and is a standing committee member of the Committee on Oncology Clinical Pharmacy of the Fujian Anti-Cancer Association. Additionally, he serves on various national and provincial committees on pharmacology.
Dr. Qiu has led and participated in numerous provincial projects and has contributed to National Science and Technology Major Projects, as well as projects funded by the National Natural Science Foundation of China. He has published over 50 papers, including those indexed by SCI. Additionally, he is a youth editorial board member and reviewer for Drug Evaluation Research and a reviewer for the Strait Pharmaceutical Journal. His research focuses on therapeutic drug monitoring, in vivo drug analysis, the pharmacokinetics and pharmacodynamics of antimicrobial agents, analysis of drug resistance, pharmaceutical genomics, human bioavailability and bioequivalence of drugs, and phase I clinical research of innovative drugs.
A/Prof. Hongqiang Qiu obtained a PhD in pharmacology and holds positions as Chief Pharmacist, Associate Professor, and Master’s Supervisor at Fujian Medical University Union Hospital. He is recognized as a High-Level Talent in Fujian Province and a key researcher at the National Drug clinical Trial Registration Institution. A/Prof. Qiu serves as the Deputy Director of the Committee on Pharmaceutical Genetics and Pharmacogenomics of the Fujian Pharmaceutical Association and is a standing committee member of the Committee on Oncology Clinical Pharmacy of the Fujian Anti-Cancer Association. Additionally, he serves on various national and provincial committees on pharmacology.
Dr. Qiu has led and participated in numerous provincial projects and has contributed to National Science and Technology Major Projects, as well as projects funded by the National Natural Science Foundation of China. He has published over 50 papers, including those indexed by SCI. Additionally, he is a youth editorial board member and reviewer for Drug Evaluation Research and a reviewer for the Strait Pharmaceutical Journal. His research focuses on therapeutic drug monitoring, in vivo drug analysis, the pharmacokinetics and pharmacodynamics of antimicrobial agents, analysis of drug resistance, pharmaceutical genomics, human bioavailability and bioequivalence of drugs, and phase I clinical research of innovative drugs.